Use of molecular and genomic data for disease surveillance in aquaculture: Towards improved evidence for decision making

被引:10
|
作者
Stark, Katharina D. C. [1 ,2 ]
Pekala, Agnieszka [3 ]
Muellner, Petra [1 ,4 ]
机构
[1] SAFOSO AG, Bern, Switzerland
[2] Royal Vet Coll, London, England
[3] Natl Inst Vet Res, Pulawy, Poland
[4] Epiinteractive, Wellington, New Zealand
关键词
ANTIMICROBIAL RESISTANCE; VETERINARY; VALIDATION;
D O I
10.1016/j.prevetmed.2018.04.011
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Diagnostic tools for the identification and confirmation of animal diseases have been evolving rapidly over the last decade, with diseases of aquatic animals being no exception. Hence, case definitions used in surveillance may now include molecular and genomic components and ultimately be based on the entire genome of a pathogen. While the opportunities brought on by this change in our ability to define and differentiate organisms are manifold, there are also challenges. These include the need to consider typing tool characteristics during sampling design, but also the re-thinking of diagnostic protocols and standards for the meaningful interpretation of the increasingly complex data presented to surveillance managers. These issues are illustrated for aquaculture using the example of multi-country surveillance of antimicrobial resistance of Aeromonas spp. strains isolated from rainbow trouts (Oncorhynchus mykiss) in Europe. In order to fully exploit the opportunities of molecular and genomic information, a multi-disciplinary approach is needed to develop harmonised diagnostic procedures and modified surveillance designs for aquaculture as well as for terrestrial animal production. This will require adjustments in the relevant standards applicable to assess food safety and trade risks.
引用
收藏
页码:190 / 195
页数:6
相关论文
共 50 条
  • [21] Making effective use of human genomic sequence data
    Jang, WH
    Chen, HC
    Sicotte, H
    Schuler, GD
    TRENDS IN GENETICS, 1999, 15 (07) : 284 - 286
  • [22] Towards Evidence-Based Decision Making in Asset Management
    Kortelainen, Helena
    Rantala, Antti
    Ahonen, Toni
    Tervo, Jesse
    15TH WCEAM PROCEEDINGS, 2022, : 312 - 323
  • [23] Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?
    Lee, Ho-Su
    Cleynen, Isabelle
    CELLS, 2019, 8 (06)
  • [24] Managing the threat of infectious disease in fisheries and aquaculture using structured decision making
    Irwin, Brian J.
    Tomamichel, Megan M.
    Frischer, Marc E.
    Hall, Richard J.
    Davis, Alaina D. E.
    Bliss, Thomas H.
    Rohani, Pejman
    Byers, James E.
    FRONTIERS IN ECOLOGY AND THE ENVIRONMENT, 2024, 22 (02)
  • [25] Improved capital budgeting decision making: evidence from Canada
    Bennouna, Karim
    Meredith, Geoffrey G.
    Marchant, Teresa
    MANAGEMENT DECISION, 2010, 48 (1-2) : 225 - 247
  • [26] Clinical Data Warehousing for Evidence Based Decision Making
    Narra, Lekha
    Sahama, Tony
    Stapleton, Peta
    DIGITAL HEALTHCARE EMPOWERING EUROPEANS, 2015, 210 : 329 - 333
  • [27] Determinants of Evidence Use in Academic Librarian Decision Making
    Koufogiannakis, Denise
    COLLEGE & RESEARCH LIBRARIES, 2015, 76 (01): : 100 - 114
  • [28] The use of scientific evidence in decision-making in the IMSS
    Perez-Cuevas, Ricardo
    Reyes-Morales, Hortensia
    Munoz-Hernandez, Onofre
    SALUD PUBLICA DE MEXICO, 2007, 49 : E277 - E279
  • [29] Leveraging genomic sequencing data to evaluate disease surveillance strategies
    Anderson, Benjamin
    Ouyang, Derek
    D'Agostino, Alexis
    Bonin, Brandon
    Smith, Emily
    Kraushaar, Vit
    Rudman, Sarah L.
    Ho, Daniel E.
    ISCIENCE, 2023, 26 (12)
  • [30] Using tuberculosis surveillance data for informed programmatic decision-making
    Nishikiori, Nobuyuki
    Morishita, Fukushi
    WESTERN PACIFIC SURVEILLANCE AND RESPONSE, 2013, 4 (01) : 1 - 3